# ::id 1
# ::snt An experimental cancer drug that works after a single round of treatment appears to be the most effective medicine yet for a rare form of leukemia , according to a study
(x13 / appear-02
	:ARG1 (x4 / drug
		:mod (x2 / experiment-01)
		:mod (x3 / cancer)
		:ARG0-of (x6 / work
			:time (x7 / after
				:op1 (x10 / round
					:mod (x9 / single)
					:consist-of (x12 / treat-03)))))
	:ARG1 (x19 / medicine
		:mod (x18 / effective
			:degree (x17 / most))
		:time (x20 / yet)
		:beneficiary (x24 / form
			:mod (x23 / rare)
			:mod (x26 / disease
				:name (n / name
					:op1 "leukemia"))))
	:ARG1 (x31 / study-01))

# ::id 2
# ::snt The drug _ called 2-chlorodeoxyadenosine , or 2-CdA _ has produced complete remissions in almost all hairy cell leukemia patients treated , and none has relapsed so far
(x / xconcept
	:x (x7 / or
		:op1 (x3 / _
			:domain (x2 / drug)
			:ARG1-of (x4 / call-01
				:ARG2 (x5 / 2-chlorodeoxyadenosine)))
		:op2 (x11 / produce-01
			:ARG0 (x9 / _
				:mod (x8 / 2-cda))
			:ARG1 (x13 / remission
				:mod (x12 / complete))
			:ARG2 (x20 / patient
				:quant (x15 / almost)
				:quant (x16 / all)
				:mod (x17 / hairy)
				:mod (x18 / cell)
				:mod (x19 / disease
					:name (n / name
						:op1 "leukemia"))
				:ARG1-of (x21 / treat-01)))
		:op2 (x26 / relapse-01
			:ARG1 x2
			:ARG0 (x24 / none)))
	:x (x23 / and))

# ::id 3
# ::snt Researchers who developed and tested the medicine report that the medicine report  may well be the drug of choice in the treatment of hairy cell leukemia
(x8 / report-01
	:ARG0 (x1 / person
		:ARG0-of (r / research-01)
		:ARG1-of (x3 / develop-02
			:ARG1 (x7 / medicine
				:ARG1-of (x5 / test-01))))
	:ARG1 (x13 / possible
		:domain (x17 / drug
			:ARG0 (x12 / report
				:mod (x11 / medicine))
			:domain (x22 / treat-03
				:ARG1 (x26 / disease
					:name (n / name
						:op1 "leukemia")
					:mod (x24 / hairy)
					:mod (x25 / cell))))))

# ::id 4
# ::snt The drug also has been used successfully against chronic lymphocytic leukemia
(x6 / use-01
	:ARG1 (x2 / drug)
	:mod (x3 / also)
	:ARG1-of (x7 / succeed-01)
	:ARG2 (x11 / disease
		:name (n / name
			:op1 "leukemia")
		:mod (x9 / chronic)
		:mod (x10 / lymphocytic)))

# ::id 5
# ::snt the medicine report  , like hairy cell leukemia , is a cancer of the white blood cells , which produce disease-fighting antibodies
(x12 / cancer
	:ARG0 (x3 / report
		:mod (x2 / medicine))
	:null_edge (x8 / disease
		:name (n / name
			:op1 "leukemia")
		:mod (x6 / hairy)
		:mod (x7 / cell))
	:ARG1 (x17 / cell
		:mod (x15 / white)
		:mod (x16 / blood)
		:ARG0-of (x20 / produce-01
			:ARG1 (x22 / antibody
				:mod (x21 / disease-fighting)))))

# ::id 6
# ::snt The latest study , published in Thursday's New England Journal of Medicine , was directed by Dr. Lawrence D. Piro of the Scripps Clinic and Research Foundation in La Jolla , Calif.
(x16 / direct-01
	:ARG1 (x3 / study
		:time (x2 / late
			:degree (m / most))
		:ARG1-of (x5 / publish-01
			:ARG0 (x19 / name
				:op1 "Lawrence"
				:op2 "D."
				:op3 "Piro"
				:ARG0-of (x24 / government-organization
					:name (n / name
						:op1 "Scripps"
						:op2 "Clinic"
						:op3 "and"
						:op4 "Research"
						:op5 "Foundation")
					:location (x31 / country
						:name (n2 / name
							:op1 "Jolla")
						:null_edge (x30 / country
							:name (n3 / name
								:op1 "La"))
						:null_edge (x33 / country
							:name (n4 / name
								:op1 "Calif.")))))
			:time (xap0 / date-entity
				:weekday (x7 / thursday)
				:ARG3 (x13 / organization
					:name (n1 / name
						:op1 "Medicine")
					:null_edge (x9 / null_tag))))))

# ::id 7
# ::snt Scripps recently made an agreement with Johnson & Johnson's Ortho Pharmaceuticals to produce and distribute the drug once the medicine report  is approved by the U.S. Food and Drug Administration
(x5 / agree-01
	:ARG0 (x1 / organization
		:name (n / name
			:op1 "Scripps"))
	:time (x2 / recent)
	:ARG1 (x7 / government-organization
		:name (n1 / name
			:op1 "Johnson"
			:op2 "&"
			:op3 "Johnson"
			:op4 "'s"
			:op5 "Ortho"
			:op6 "Pharmaceuticals"))
	:ARG1 (x15 / and
		:op1 (x14 / produce-01
			:ARG1 (x18 / drug)
			:time (x24 / approve-01
				:ARG1 (x22 / report
					:mod (x21 / medicine))
				:ARG0 (x28 / food
					:null_edge (x29 / null_tag
						:op2 (x30 / government-organization
							:name (n2 / name
								:op1 "Drug"
								:op2 "Administration"))))))
		:op3 (x16 / distribute-01)))

# ::id 8
# ::snt In the published work , doctors gave the drug to 12 patients as far back as four years ago
(x4 / work-01
	:ARG1-of (x3 / publish-01)
	:ARG0 (x6 / doctor)
	:ARG1 (x9 / drug)
	:ARG2 (x12 / patient
		:quant 12
		:mod (x15 / back)
		:time (x17 / date-entity)))

# ::id 9
# ::snt In 11 , the disease disappeared and doctors  remain disease free
(x7 / and
	:op1 (x6 / disappear-01
		:duration 11
		:ARG1 (x5 / disease))
	:op2 (x9 / remain-01
		:ARG1 11
		:ARG1 (x8 / doctor)
		:ARG3 (x11 / free-41
			:ARG2 (x10 / disease
				:ARG1 x8))))

# ::id 10
# ::snt In all , the Scripps doctors have treated 24 patients with almost complete success
(x8 / treat-01
	:ARG0 (x6 / doctor
		:mod (x5 / organization
			:name (n / name
				:op1 "Scripps")))
	:ARG1 (x10 / patient
		:quant 24)
	:ARG2 (x14 / succeed-01
		:mod (x13 / complete
			:degree (x12 / almost))))

# ::id 11
# ::snt However , the Scripps doctors  caution that longer follow up will be necessary before the Scripps doctors  can be sure the Scripps doctors  have actually cured the disease
(x6 / caution-01
	:ARG0 (x5 / doctor
		:mod (x4 / organization
			:name (n / name
				:op1 "Scripps")))
	:ARG1 (x13 / necessary
		:null_edge (x9 / follow-02)
		:time (x14 / before
			:ARG0 (x17 / doctor
				:mod (x16 / organization
					:name (n1 / name
						:op1 "Scripps")))
			:op1 (x18 / possible)
			:op1 (xap0 / and
				:op2 (x26 / cure-01
					:ARG0 (x23 / doctor
						:mod (x22 / organization
							:name (n2 / name
								:op1 "Scripps")))
					:mod (x25 / actual)
					:ARG1 (x28 / disease))))))

# ::id 12
# ::snt Two other treatments for hairy cell leukemia have been developed in recent years
(x10 / develop-02
	:ARG1 (x3 / treat-03
		:quant 2
		:mod (x2 / other)
		:purpose (x7 / disease
			:name (n / name
				:op1 "leukemia")
			:mod (x5 / hairy)
			:mod (x6 / cell)))
	:time (x13 / temporal-quantity
		:unit (y / year)
		:mod (x12 / recent)))

# ::id 13
# ::snt the Scripps doctors  are interferon and deoxycoformycin , a drug that is similar to 2-CdA
(x6 / and
	:op1 (x5 / interferon
		:ARG0 (x3 / doctor
			:mod (x2 / scripps)))
	:op2 (x7 / deoxycoformycin
		:ARG1 (x10 / drug
			:ARG1-of (x13 / resemble-01
				:op (s / similar)
				:ARG2 (x15 / 2-cda)))))

# ::id 14
# ::snt However , interferon is less effective , and both of those treatments produce serious side effects
(x8 / and
	:op1 (x6 / effective
		:domain (x3 / interferon)
		:degree (x5 / less))
	:op2 (x13 / produce-01
		:ARG3 (x12 / treat-03)
		:ARG1 (x16 / effect-01
			:mod (x14 / serious)
			:mod (x15 / side))))

# ::id 15
# ::snt By contrast , the only unwanted effect of 2-CdA was a few days of fever
(x7 / effect-01
	:beneficiary (x2 / contrast-01)
	:mod (x5 / only)
	:mod (x6 / unwanted)
	:ARG1 (x9 / 2-cda)
	:ARG0 (x15 / fever
		:quant (x12 / few)
		:quant (x13 / temporal-quantity
			:unit (d / day))))

# ::id 16
# ::snt Patients experienced no nausea , hair loss , rashes or other symptoms typical of cancer therapy
(x2 / experience-01
	:ARG0 (x1 / patient)
	:ARG1 (x10 / or
		:op1 (x4 / nausea
			:polarity -)
		:op2 (x7 / loss
			:ARG1 (x6 / hair))
		:op2 (x9 / rash)
		:op2 (x12 / symptom
			:mod (x11 / other)
			:mod (x13 / typify-01
				:domain (x16 / therapy
					:mod (x15 / cancer))))))

# ::id 17
# ::snt Also unlike other treatments , this one appears to work after a single seven-day course of therapy
(x8 / appear-02
	:ARG1 (x4 / treat-03
		:mod (x1 / also)
		:mod (x3 / other))
	:ARG1 (x7 / one
		:mod (x6 / this))
	:ARG1 (x10 / work-01
		:ARG0 x7
		:time (x11 / after
			:op1 (x15 / course-01
				:ARG1 (x17 / therapy)))))

